Sector portfolio · VC firm · United States
NFX's Biotech portfolio
NFX has backed 11 Biotech startups in rounds we track, $315M between them, shown by the stage each has reached. The best-funded is Twostep Therapeutics.
Funding by segment
- Pre-seed and seed$73M6
- Series A$166M3
- Stage not reported$76M2
Where they are based
- United States7$210M
- United Kingdom2$29M
- Austria1$56M
United States
United Kingdom
AustriaFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M3
- $10M to $50M5
- $50M to $250M3
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States7
- United Kingdom2
- Austria1
Startups by country, 3 countries in all.
Segment by segment
Pre-seed and seed
6 startups · $73M raised
Eleven TherapeuticsEleven Therapeutics is a biotechnology company founded in 2020, specializing in next-generation RNA therapeutics.United Kingdom$22M
Line 5Line 5 offers fully fund and finance vehicle protection plans for automobiles, SUVs, trucks and more.-$20M
ImmuneBridgeImmuneBridge is a biotechnology company based in San Francisco, founded in 2018.United States$13M
Pangea Therapeutics Ltd.Pangea Therapeutics Ltd.United States$7.0M
Cyclana BioCyclana Bio is a biotechnology company based in Cambridge, UK, dedicated to advancing women's health, particularly in the area of United Kingdom$6.7M
ZipBioCompressing biology to develop the next generation of therapiesUnited States$4.0M
Series A
3 startups · $166M raised
TwoStep TherapeuticsTwoStep Therapeutics is a biotechnology company focused on developing targeted therapies for solid tumors.United States$84M
CentivaxCentivax, Inc.United States$71M
Genome CompilerGenome Compiler is a computer aided design and collaboration platforms for the synthetic biology industryUnited States$12M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names NFX as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like NFX?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.